Skip to content
Screener

Strata Critical Medical SRTA Q3 2025 earnings

Reported November 10, 2025 · Before market open

Revenue$49.3MMiss by $11.1M
EPS-$0.06Miss by $0.04
Revenue estimate$60.4M
EPS estimate-$0.02

Next report

Nov 9, 2026 (In 3 weeks)
Revenue estimate$72.7M
EPS estimate$0.01

Financials

Q3 2025

Income statement

See full
Revenue$49.3M+36.7%
Gross profit$11.6M+54.7%
Operating income-$5.6M+20.7%
Net income$57.4M+3,038%
EPS (diluted)$0.70+2,433%

Balance sheet

See full
Cash & equivalents$23.0M+7.5%
Total debt$3.5M-85.4%
Total equity$283.0M+21.2%
Total assets$335.1M+18.4%

Cash flow

See full
Operating cash flow-$37.3M—
CapEx$2.8M-69.6%
Free cash flow-$40.1M-1,259%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$430.76M—
Enterprise value$411.21M—
P/E10.7×—
P/S2.2×—

Profitability

See full
Gross margin21.5%+0.3pp
Operating margin-11.5%-4.5pp
Net margin21%+13.6pp
FCF margin-28.4%+40.0pp

Returns & leverage

See full
Return on equity15.6%+10.0pp
Debt / equity0×-0.1×
Current ratio4.4×-1.9×

FAQ

When did Strata Critical Medical report Q3 2025 earnings?
Strata Critical Medical (SRTA) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Strata Critical Medical's Q3 2025 revenue and EPS?
Strata Critical Medical reported revenue of $49.3M and eps of $-0.06 for Q3 2025.
Did Strata Critical Medical beat estimates in Q3 2025?
Revenue missed the consensus estimate of $60.4M by $11.1M. EPS missed the consensus estimate of $-0.02 by $0.04.
How did Strata Critical Medical's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 34.2% from $74.9M a year earlier and eps declined 100.0% from $-0.03.
Where can I find Strata Critical Medical's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-050785) and the 10-Q periodic report (0001628280-25-050870) directly on SEC EDGAR. The filing index links above go to sec.gov.